Insights into the Global Cytomegalovirus (CMV) Infection Treatment and Diagnosis Market

 Cytomegalovirus (CMV) is a herpes virus that lies dormant in the human body. CMV infection can affect people of all ages all over the world. CMV is a contagious disease that can be spread through saliva, blood, urine, sperm, and breast milk. The presence of CMV infection can be identified using a variety of testing methods, which can be used to study the global cytomegalovirus infection treatment and diagnosis market:

  • Serologic examination
  • Test for polymerase chain reaction (PCR)

In pregnant women and immunocompromised people, CMV diagnosis is crucial. In laboratories, the enzyme-linked immunoassay test is the most extensively used serologic test for CMV infection.Furthermore, the PCR technique is commonly used for saliva and urine samples. Because the condition is asymptomatic, the majority of cases go untreated at an early stage.

Treatment options for CMV infections on the market

People who have been diagnosed with a high risk of CMV infection may be administered antiviral medicines to prevent the disease from advancing to an active stage. CMV infection has no treatment at the moment. Some of the most widely given antiviral medicines include ganciclovir, valganciclovir, Cidofovir, Valacyclovir, and Foscarnet. In some cases, CMV immune globulin, which contains antibodies (proteins), may be used to prevent CMV infection. The introduction of some drugs in the pipeline, such as Cytovir CMV, Letermovir, CytoTect CP 70, Brincidofovir, and ASP0113, is projected to fuel the global CMV infection treatment and diagnosis market growth in the near future.

Insights into the global market for CMV infection treatment and diagnostics

Furthermore, new CMV cases being diagnosed will be a driving force for the worldwide cytomegalovirus infection treatment and diagnosis market. According to the Public Health Agency of Canada, CMV antibody is found in the bodies of 40 percent to 100 percent of the world's population. Immunocompromised individuals (HIV, organ transplant), premature infants, newborns, and those born with congenital CMV are all at increased risk of serious disease from CMV infection.In the United States, one in every 150 infants is born with congenital cytomegalovirus (CMV) infection, according to the Centers for Disease Control and Prevention (CDC). Only one out of every five infants infected with CMV develops long-term health issues. The CMV infection treatment and diagnosis market is expected to develop due to rising infection rates and desire for improved treatment options.


Market for CMV infection treatment and diagnosis: A regional perspective

In developed regions such as North America and Europe, where advanced diagnostic and treatment facilities are available, early diagnosis practises will boost the global CMV infection treatment and diagnostics market. Ensured accessibility and healthcare investment in emerging nations would be crucial for market players in the diagnosis and treatment of CMV infection to achieve greater returns on investments.

Merck & Co. Inc., Cell Medical Ltd., Chimerix, Inc., Affymetrix, Inc., Abbott Laboratories, Inc., Becton, Dickinson and Company, Johnson & Johnson, Bio-Rad Laboratories, Inc., and F. Hoffmann-La Roche Ltd. are some of the major players in the global cytomegalovirus infection treatment and diagnosis market.

Comments

Post a Comment

Popular posts from this blog

One of the primary factors driving the Worldwide Frosting and Icing Market is the rising demand for cakes and pastries.

Image
  Market Dynamics The increased demand for cakes and pastries is one of the key reasons driving the global frosting and icing market . According to Agriculture and Agri-Food Canada, the value of cakes sold in the United Kingdom increased by an average of 2% every year from 2012 to 2017, outpacing the CAGR by 1.5 percent (2007-2012). Furthermore, an increase in the number of bakeries as a result of increased urbanisation and rising income, which leads to a burgeoning food sector, is fueling the expansion of the frosting and icing market. In 2015, India's food processing business was valued at US$ 258 billion, according to the India Brand Equity Foundation (IBEF), ranking fifth in terms of consumption, output, and exports. Health issues, such as increased obesity, are, however, restraining market growth. In 2017, 36.5 percent of adults in the United States were obese, according to the Centers for Disease Control and Prevention (CDC), which impeded market expansion. To tackle this, a ...
Read more

Orthopedic Power Tools Market predicted to be growing at a CAGR of 3.50 percent over the forecast period (2020-2027)

Image
Various orthopaedic illnesses in the musculoskeletal systems, such as musculoskeletal trauma, spine diseases, musculoskeletal injuries, and infections, are treated by orthopaedics. Orthopedic power tools are lightweight, user-friendly, and easy to handle when performing orthopaedic surgery when compared to traditional heavy orthopaedic tools. Electric powered orthopaedic tools, battery operated power systems, and pneumatic power tools are the three types of orthopaedic power tools. In 2020, the global orthopaedic power tools market is predicted to be worth US$ 943.8 million, growing at a CAGR of 3.50 percent over the forecast period (2020-2027). One of the reasons predicted to drive market expansion during the forecast period is the rising frequency of spinal injuries. According to a report issued by the National Spinal Cord Injury Statistical Center in 2018, the incidence of spinal cord injury in the United States is roughly 54 instances per one million individuals, with around 17,70...
Read more

The Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Market will continue to increase as the number of ambulatory individuals seeking treatment for skin and skin structure infections rises

Image
Acute Bacterial Skin and Skin Structure Infections (ABSSSI) are infections of the epidermis, dermis, and subcutaneous tissues that affect the skin and soft tissues. ABSSSI is defined by the US FDA as lesions having cellulitis/erysipelas, wound infections, and large cutaneous abscesses with a surface area of at least 75 cm2. ABSSSI is caused by pathogens such as Methicillin-sensitive Staphylococcus aureus (MSSA), Methicillin-resistant Staphylococcus aureus (MRSA), Beta-hemolytic Streptococcus, E. coli, Enterococcus faecalis, and Pseudomonas aeruginosa. The rising incidence of drug-resistant strains, particularly in Staphylococcus spp. and Enterococcus spp., makes this infection challenging to treat. The ABSSSI market is predicted to grow at a steady pace, thanks to an increasing number of patients suffering from these conditions and a significant number of pipeline treatments expected to be authorised during the forecast period. Acute Bacterial Skin and Skin Structure Infections (ABSSSI...
Read more